Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Join us as we discuss how frequently patients with stable hypertension should monitor their blood pressure at home. Hear insights from two trials to help you provide evidence-based, cost-conscious guidance—reducing unnecessary alarms while supporting better long-term management.

Episode resource links:

Guest: Robert A. Baldor MD, FAAFP

Thoughts? Suggestions? Email us at [email protected]

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Cognitive decline risk may be reduced through modifiable lifestyle factors, creating an opportunity for early intervention in primary care. Join us as we review findings from the US POINTER trial, which evaluated the impact of structured vs. self-guided lifestyle interventions on the risk of cognitive decline in older adults. Come away with tips to apply this evidence in real-world scenarios with your patients.

Episode resource links:

Guest: Jillian Joseph, MPAS, PA-C

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at [email protected] 

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: In this episode, we explore the relationship between caffeine consumption and suicide risk. Hear how coffee may offer protective effects—while energy drinks raise concern—and gain practical tips for screening patients for caffeine and substance use as part of suicide risk assessment in primary care.

Episode resource links:

Low, C.E.; Chew, N.S.M.; Loke, S.; Tan, J.Y.; Phee, S.; Lee, A.R.Y.B.; Ho, C.S.H. Association of Coffee and Energy Drink Intake with Suicide Attempts and Suicide Ideation: A Systematic Review and Meta-Analysis. Nutrients 2025, 17, 1911. https://doi.org/10.3390/ nu17111911

Costantino, A., Maiese, A., Lazzari, J., Casula, C., Turillazzi, E., Frati, P., & Fineschi, V. (2023). The Dark Side of Energy Drinks: A Comprehensive Review of Their Impact on the Human Body. Nutrients, 15(18), 3922. https://doi.org/10.3390/nu15183922

Guest: Jill M. Terrien PhD, ANP-BC 

Thoughts? Suggestions? Email us at [email protected]

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Many patients turn to low- and no-calorie sweeteners to help with weight loss and lower diabetes risk, but do these alternatives actually deliver? In this episode, we review common artificial sweeteners and explore evidence on hunger, cardiovascular, diabetes, and dementia risks to understand how sugar substitutes can impact long-term health outcomes in your patients.

Episode resource links:

Guest: Robert A. Baldor MD, FAAFP

Music Credit: Matthew Bugos

Thoughts? Suggestions? Email us at [email protected] 

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Experiences of significant pain and anxiety during intrauterine device (IUD) insertion may lead patients to forgo this effective contraceptive option. Listen in as we discuss how to reduce procedural pain, address anxiety, and foster trust using updated guidelines and shared decision-making to improve patient satisfaction and support informed contraceptive choices.

Episode resource links:

Guest: Mariyan L. Montaque, DNP, FNP-BC

Thoughts? Suggestions? Email us at [email protected]

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Microscopic hematuria is common in primary care, but not every patient needs an urgent urology referral. Tune in to learn how to apply the latest evidence-based guidelines to risk-stratify patients and confidently manage workup and follow-up from your clinic, improving care while reducing unnecessary testing.

Episode resource links:

Guest: Robert A. Baldor MD, FAAFP

Thoughts? Suggestions? Email us at [email protected]

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Treating hypertension within the first month can significantly improve long-term blood pressure control. This episode reviews new evidence and practical strategies to help you initiate timely therapy, optimize follow-up, and improve outcomes for patients with newly diagnosed, uncontrolled hypertension. Gain actionable insights to close a critical care gap.

Episode resource links:

Guest: Jill M. Terrien PhD, ANP-BC 

Thoughts? Suggestions? Email us at [email protected]

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: Many patients are still hesitant about the shingles vaccine, but the benefits go far beyond preventing a painful rash. Hear how varicella zoster vaccination can also reduce the risks of postherpetic neuralgia, dementia, and cardiovascular events, giving you powerful tools to guide more informed patient decisions.

Episode resource links:

Guest: Robert A. Baldor MD, FAAFP

Thoughts? Suggestions? Email us at [email protected]

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: The healthcare landscape is evolving rapidly, and clinicians are navigating conflicting guidance on established, evidence-based recommendations. Recent news suggest acetaminophen use during pregnancy causes autism spectrum disorder (ASD), which is not the consensus of medical experts based on available data. When guidance from various sources conflicts with established research, clinicians face challenges in providing evidence-based care. Join us to review the current evidence on acetaminophen and ASD risk. 

Episode resource links:

Ahlqvist VH, Sjöqvist H, Dalman C, et al. Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability. JAMA. 2024;331(14):1205–1214. doi:10.1001/jama.2024.3172

Damkier, P., Gram, E. B., Ceulemans, M., Panchaud, A., Cleary, B., Chambers, C., Weber-Schoendorfer, C., Kennedy, D., Hodson, K., Grant, K. S., Diav-Citrin, O., Običan, S. G., Shechtman, S., & Alwan, S. (2025). Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism Spectrum Disorder. Obstetrics and gynecology, 145(2), 168–176. https://doi.org/10.1097/AOG.0000000000005802

Ji Y, Azuine RE, Zhang Y, et al. Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder in Childhood. JAMA Psychiatry. 2020;77(2):180–189. doi:10.1001/jamapsychiatry.2019.3259

Hirota T, King BH.  Autism Spectrum Disorder: A Review. JAMA. 2023;329(2):157–168. doi:10.1001/jama.2022.23661

Liu, X., Zou, M., Sun, C., Wu, L., & Chen, W. X. (2022). Prenatal Folic Acid Supplements and Offspring's Autism Spectrum Disorder: A Meta-analysis and Meta-regression. Journal of autism and developmental disorders, 52(2), 522–539. https://doi.org/10.1007/s10803-021-04951-8

DSM-5-TR: Neurocognitive Disorders Supplement; October 2022. https://psychiatryonline.org/pb-assets/dsm/update/DSM-5-TR_Neurocognitive-Disorders-Supplement_2022_APA_Publishing.pdf

https://www.npr.org/sections/shots-health-news/2025/09/06/nx-s1-5532143/hhs-responds-to-report-about-autism-and-acetaminophen

Guest: Susan Feeney, DNP, FNP-BC, NP-C

Thoughts? Suggestions? Email us at [email protected] 

Credits: 0.25 AMA PRA Category 1 Credit™

Overview: The obesity epidemic has fueled a demand for weight loss medications. Trials have directly compared medications—specifically glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—with a recent study doing just that. Tune in as we explore the evidence comparing semaglutide and tirzepatide for weight loss outcomes up to 1 year.

Episode resource links:

Guest: Alan M. Ehrlich, MD, FAAFP

Thoughts? Suggestions? Email us at [email protected]